Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P060001/S060

PROTEGE GPS AND PROTEGE RX CAROTID STENT SYSTEMS

Medtronic Vascular, Inc. · Decision date Nov 5, 2026

MEDTECHLEDGER EXPLANATIONP060001/S060

What did the FDA decide?

The FDA recorded decision OK30 on 2026-11-05 for P060001/S060, a 30-Day Notice supplement to the premarket approval for the Protege GPS and Protege RX Carotid Stent Systems, submitted by Medtronic Vascular, Inc. The supplement reason is listed as a process change involving manufacturer, sterilizer, packager or supplier.

The recorded statement covers approval of manufacturing and process validation changes for the delivery systems of the EverFlex and Protege GPS Self-Expanding Peripheral Stent Systems. This is a supplement-level decision about those delivery-system changes, not a new approval of the full stent systems. The source record does not describe the specific manufacturing steps, validation methods or supplier details, and it does not address clinical performance or labeling.

FDA approval order statement

approval for manufacturing and process validation changes for the delivery systems of the EverFlex and Protege GPS Self-Expanding Peripheral Stent Systems
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Nov 5, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P060001/S060
Regulatory pathway
PMA supplement
Product code
NIM
Decision code
OK30
Decision date
Nov 5, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stent, carotid.

Product code
NIM
FDA device class
3

For the original device and its historical approval scope, see PMA P060001. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P060001 · Original PMA

    PROTEGE GPS AND PROTEGE RX CAROTID STENT SYSTEMS

  2. P060001/S060 received

    Application receipt date recorded by FDA.

  3. P060001/S059 · Related supplement

    Protégé GPS Self-Expanding Peripheral Stent System; Protégé RX Self-Expanding Carotid Stent System

  4. P060001/S060 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P060001. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P060001

Explore the linked device profile

Other records with product code NIM

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Vascular, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
3033 Campus Dr., Plymouth, MN, 55441

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records